HERMES MEDICAL: what changed
What changed
HERMES MEDICAL
filed annual accounts (NBB)
Net result for the year
€117,294
2024 · €98,400+€18,894
Equity
€207,885
2024 · €90,591+€117,294
Cash
€125,275
2024 · €136,726-€11,451
Balance sheet total
€318,633
2024 · €259,471+€59,162
Largest movements
Assets
- Current investments +€52,000
up €52,000 (+104%), from €50,000 to €102,000
- Receivables within one year +€13,482
new in 2025: €13,482
- Cash -€11,451
down €11,451 (-8.4%), from €136,726 to €125,275
mainly Other debts (-€55,410) and Current investments (-€52,000)
- Deferred charges and accrued income +€4,826
new in 2025: €4,826
Equity and liabilities
- Profit (loss) carried forward +€117,294
new in 2025: €117,294
- Other debts -€55,410
down €55,410 (-40.9%), from €135,360 to €79,950
- Tax, wage and social debts -€3,808
down €3,808 (-16.6%), from €22,891 to €19,084
Income statement
- Gross operating margin +€30,968
up €30,968 (+25.0%), from €123,862 to €154,831
- Taxes +€12,385
up €12,385 (+42.7%), from €28,979 to €41,364
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€98,400
Gross operating margin
+€30,968
Depreciation
+€420
Other operating charges
-€163
Financial income
+€25
Financial charges
+€29
Taxes
-€12,385
Result 2025
€117,294
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€41,613
Investment
-€53,049
Financing
-€15
Cash 2024
€136,726
From operations (derived)
+€41,613
Net result for the year
+€117,294
Depreciation
+€744
Receivables within one year
-€13,482
Deferred charges and accrued income
-€4,826
Trade debts
+€1,102
Tax, wage and social debts
-€3,808
Other debts
-€55,410
Investment (derived)
-€53,049
Investment in fixed assets (net)
-€1,049
Current investments
-€52,000
Financing
-€15
Current portion of long-term debt
-€15
Cash 2025
€125,275
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €259,471 | €318,633 | +€59,162 | +22.8% |
| Fixed assets | 21/28 | €2,745 | €3,051 | +€305 | +11.1% |
| Tangible fixed assets | 22/27 | €2,745 | €3,051 | +€305 | +11.1% |
| Plant, machinery and equipment | 23 | €431 | €1,100 | +€669 | +155% |
| Furniture and vehicles | 24 | €806 | €605 | -€201 | -25.0% |
| Other tangible fixed assets | 26 | €1,508 | €1,346 | -€163 | -10.8% |
| Current assets | 29/58 | €256,726 | €315,583 | +€58,857 | +22.9% |
| Amounts receivable after more than one year | 29 | €70,000 | €70,000 | = | 0.0% |
| Other amounts receivable | 291 | €70,000 | €70,000 | = | 0.0% |
| Amounts receivable within one year | 40/41 | - | €13,482 | +€13,482 | |
| Other amounts receivable | 41 | - | €13,482 | +€13,482 | |
| Current investments | 50/53 | €50,000 | €102,000 | +€52,000 | +104% |
| Cash at bank and in hand | 54/58 | €136,726 | €125,275 | -€11,451 | -8.4% |
| Deferred charges and accrued income | 490/1 | - | €4,826 | +€4,826 | |
| Total equity and liabilities | 10/49 | €259,471 | €318,633 | +€59,162 | +22.8% |
| Equity | 10/15 | €90,591 | €207,885 | +€117,294 | +129% |
| Contributions | 10/11 | €74,400 | €74,400 | = | 0.0% |
| Reserves | 13 | €16,191 | €16,191 | = | 0.0% |
| Tax-exempt reserves | 132 | €8,751 | €8,751 | = | 0.0% |
| Distributable reserves | 133 | €7,440 | €7,440 | = | 0.0% |
| Profit (loss) carried forward | 14 | - | €117,294 | +€117,294 | |
| Amounts payable | 17/49 | €168,880 | €110,748 | -€58,132 | -34.4% |
| Amounts payable within one year | 42/48 | €168,880 | €110,748 | -€58,132 | -34.4% |
| Current portion of amounts payable after more than one year | 42 | €8,461 | €8,446 | -€15 | -0.2% |
| Trade debts | 44 | €2,167 | €3,269 | +€1,102 | +50.8% |
| Suppliers | 440/4 | €2,167 | €3,269 | +€1,102 | +50.8% |
| Taxes, remuneration and social security | 45 | €22,891 | €19,084 | -€3,808 | -16.6% |
| Taxes | 450/3 | €22,891 | €19,084 | -€3,808 | -16.6% |
| Other amounts payable | 47/48 | €135,360 | €79,950 | -€55,410 | -40.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,163 | €744 | -€420 | -36.1% |
| Other operating charges | 640/8 | - | €163 | +€163 | |
| Gross operating margin | 9900 | €123,862 | €154,831 | +€30,968 | +25.0% |
| Operating profit (loss) | 9901 | €122,699 | €153,924 | +€31,225 | +25.4% |
| Financial income | 75/76B | €6,812 | €6,837 | +€25 | +0.4% |
| Recurring financial income | 75 | €6,812 | €6,837 | +€25 | +0.4% |
| Financial charges | 65/66B | €2,132 | €2,103 | -€29 | -1.4% |
| Recurring financial charges | 65 | €2,132 | €2,103 | -€29 | -1.4% |
| Profit (loss) for the period before taxes | 9903 | €127,378 | €158,657 | +€31,279 | +24.6% |
| Income taxes | 67/77 | €28,979 | €41,364 | +€12,385 | +42.7% |
| Profit (loss) for the period | 9904 | €98,400 | €117,294 | +€18,894 | +19.2% |
| Profit (loss) for the period to be appropriated | 9905 | €98,400 | €117,294 | +€18,894 | +19.2% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 3 November 2026 via checked.be.